NCT00002111View on ClinicalTrials.gov

A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Saquinavir

Trial Locations (1)

943055107

Stanford Univ School of Medicine, Stanford

All Listed Sponsors

lead

Stanford University

OTHER